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Alternative splicing (AS) is one of the main contributors to transcriptome diversity and functional 
complexity involved in the process of neuronal development. Evidence suggests that many 
splicing regulators and alternative splicing events are neuron-specific and aberrations in the 
regulation of these events have been linked to various neurodevelopmental disorders. N1-Src is 
an evolutionarily conserved neuronal splice variant of the ubiquitous tyrosine kinase c-Src. It has 
been implicated in neural development and as a prognostic indicator in neuroblastoma, a 
childhood cancer that is caused by failure of neural crest cells to differentiate. Results from 
knockdown experiments where N1 exon inclusion was prevented with splice-blocking antisense 
morpholino oligos revealed that N1-Src is a key regulator of primary neurogenesis in Xenopus. 
Preliminary short and long read RNA-Seq data from Xenopus embryos suggest a role for N1-
Src in regulation of an alternative splicing programme during early neurogenesis, with transcripts 
encoding the splicing/RNA processing machinery themselves being the most spliced targets. 
This study aimed to further describe the N1-Src-regulated splicing network in the developing 
Xenopus nervous system using bioinformatic analysis of various publicly available and 
Evans/Isaacs lab RNASeq datasets.  A differential splicing (DS) analysis pipeline was developed 
to detect and quantify alternative splicing events that occur during early stages of Xenopus 
embryo development relevant to neurogenesis. By correlating alternative splicing quantifications 
with RNA-binding protein motif enrichment analysis, this project proposed mechanisms for Src 
regulation of alternative splicing. 
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Chapter 1: Introduction 
1.1: Alternative splicing  
 
RNA splicing is an mRNA processing mechanism occurring in eukaryotic organisms whereby 
the core splicing machinery, the spliceosome, binds the conserved splice sites, removes 
introns and ligates exons together to generate mature mRNA (Jurica and Roybal, 2013). The 
spliceosome complex comprises five small nuclear ribonucleoprotein particles (snRNPs) and 
a large number of auxiliary proteins. A conserved set of cis-acting elements known as the core 
splicing signals (5′ and 3′ splice sites, branch site, and polypyrimidine tract) guides the 
interactions between spliceosomal components and pre-mRNA (Singh, 2002). The 
spliceosome assembly begins with the recognition of the 5′ splice site by the snRNP U1 and 
the binding of splicing factor 1 (SF1) to the branch point and of the U2 auxiliary factor (U2AF) 
to the polypyrimidine tract and 3′ terminal AG (Chen and Manley, 2009; Wang et al., 2015). 
Splice site selection is controlled by many separate components, including non-spliceosomal 
splicing regulatory factors (Jangi et al., 2014; Matera and Wang, 2014), RNA secondary 
structures (McManus and Graveley, 2011), RNA polymerase elongation speed (Fong et al., 
2014), and epigenetic regulation (Luco et al., 2010).  
 
Alternative splicing (AS) is a highly regulated process by which different pairs of splice sites 
are selected to produce multiple RNA and protein isoforms from a single gene. Trans-acting 
splicing factors (SFs) bind to enhancer or silencer motifs close to 5′ and 3′ splice acceptor sites 
to promote or prevent the usage of a particular splice site by the spliceosome (Figure 1). The 
serine/arginine-rich (SR) protein family generally play a role in promoting spliceosome 
formation and binding of splicing machinery to the new RNA transcript, whilst the 
heterogeneous nuclear ribonucleoproteins (hnRNPs) often function as antagonists to SR-
protein-regulated alternative splicing events (Figure 1). hnRNPs bind to exon splicing silencers 





Figure 1. An overview of the regulation of alternative splicing.  
SR proteins bind to exonic splicing enhancers (ESEs) and U-rich intronic splicing enhancers 
(ISEs) to stimulate the binding of U2 small nuclear ribonucleoprotein (snRNP) to the upstream 
3′ splice site (ss) or the binding of the U1 snRNP to the downstream 5′ ss. SR proteins function 
with other splicing co-activators, such as transformer 2 (TRA2). hnRNPs bind ESSs and ISSs 
and prevent binding of the snRNPs. 
 
In addition to generating functionally distinct protein isoforms, AS may lead to changes in 
localization of proteins, their post-translational modifications or binding affinities to ligands. AS 
can also control gene expression levels. This is accomplished through different mechanisms, for 
example, by intron retention (IR) or inclusion of alternative exons containing premature 
termination codons (PTC) into the mRNA. PTC-containing transcripts are exported to the 
cytoplasm and targeted to the nonsense-mediated decay (NMD) pathway (Lareau et al., 2007). 
Many vertebrate introns contain PTCs, however IR transcripts can also be degraded by a 
mechanism independent of NMD, which requires components of the nuclear RNA surveillance 
machinery, including the nuclear pore-associated protein Tpr and the exosome complex (Yap et 
al., 2012). Many splicing factors, including polypyrimidine-tract-binding protein 1 (PTBP1), 
autoregulate expression levels in this way by binding their own pre-mRNAs and promoting 
unproductive splicing events (Wollerton et al., 2004; Pervouchine et al., 2019; Ding et al., 2020). 
Moreover, AS can generate alternative 5′ and 3′ untranslated regions (UTRs), which impact 
translation efficiency, mRNA stability and localization in the cytoplasm (Hughes, 2006).  
1.2: Splicing and neural development  
AS role in generating complex proteomic diversity explains the correlation between AS and the 
complexity of vertebrate central nervous systems. Vertebrate neural development involves 
dramatic morphological and functional changes in individual cells as they differentiate from 
neural progenitors (NPCs) to neurons. The neuronal cell fate depends on its positioning along 
the anterior-posterior and dorsal-ventral neural axis of the vertebrate embryo. Patterning of 
this axis is shaped through position-dependent gradients of signalling molecules. Alternative 
splicing and RNA-binding proteins along with other various signalling pathways and 
transcription factors that respond to these gradients are responsible for the development of 
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correct functional neural cell types with specific transcript and protein expression profiles at 
the correct place and time (Yeo et al., 2004; Raj and Blencowe, 2015; Weyn-Vanhentenryck 
et al., 2018). A large body of evidence suggests that neurons have developed unique systems 
for RNA processing, with many RNA binding proteins (RBPs) being specifically expressed in 
neurons. Mutations in neuron-specific RBPs and aberrations in neural AS patterns have been 
linked to neurological disorders (Licatalosi and Darnell, 2006). Misregulation of splicing has 
been repeatedly implicated in autism spectrum disorder (Irimia et al., 2014; Gonatopoulos-
Pournatzis et al., 2020). 
 
While most tissue differential splicing (DS) patterns are species-specific in vertebrates, the 
alternative exon inclusion events in vertebrate brains are highly conserved (Madgwick et al., 
2015). This suggests the existence of a core set of conserved functions for AS across 
vertebrate nervous systems. However, little is known about the in vivo functions of the SFs that 
are responsible for these conserved splicing events or the functions of the individual AS events 
that are controlled by these factors. 
 
Data from RNASeq and cross-linking and immunoprecipitation (CLIP) experiments have been 
combined to create RNA splicing maps. These maps correlate the RBP binding sites with their 
effect on AS regulation (Witten and Ule, 2011). These genome-wide maps suggested that 
PTBP1/2 and RBFOX proteins antagonistically modulate the NPC-to-neuron transition by 
regulating neuron-specific exon inclusion. RBFOX binding in the intron downstream from 
alternatively spliced exons increases exon inclusion, whilst upstream PTBP1 binding has been 
shown to prevent exon inclusion (see below, Weyn-Vanhentenryck et al., 2014; Li et al., 2015). 
PTBP1 expression is high in nonneuronal and neural stem cells, where it promotes exon 
skipping in its neuronal paralogue PTBP2/nPTB. The resulting introduction of PTC into Ptbp2 
transcripts results in its degradation via NMD (Spellman et al., 2007). During differentiation 
Ptbp1 is downregulated by neuron-specific microRNA miR-124, which allows for Ptbp2 
upregulation at later stages in development (Makeyev et al., 2007; Zhang et al., 2016b)). 
Rbfox1/2/3 in turn reach highest expression levels in differentiated neurons ((Makeyev et al., 
2007; Zhang et al., 2016b). Ptbp2 is also subject to autoregulation and cross-regulation by 
RBFOX2 via NMD (Jangi et al., 2014). 
 
RBFOX proteins are exceptional in their ability to recognize a long well-defined motif 
(U)GCAUG (Jin et al., 2003), while most other splicing factors recognize short (∼3–7 nt) and 
degenerate sequence motifs, which occur frequently in pre-mRNAs. This limits the ability of 




RBPs have developed different mechanisms to improve their binding specificity. Many RBPs 
utilise their modular structures to bind RNA with multiple RNA-binding domains (RBDs). For 
example, neuron-specific Nova binds to clusters of YCAY (Y = C/T). Its binding to exonic 
clusters blocks U1 snRNP binding and prevents exon inclusion, whereas Nova binding to an 
intronic YCAY cluster downstream of the regulated exon enhances spliceosome assembly 
and exon inclusion (Ule et al., 2006; Zhang et al., 2010).  
 
Similarly to RBPs, many short exons of 3 to 27 nt, known as microexons, are predominantly or 
exclusively expressed in the nervous system. Differential inclusion of neuron-specific 
microexons is the most highly conserved splicing event during neural development, with 
inclusion increasing as differentiation progresses (Irimia et al., 2014; Torres-Méndez et al., 
2019). The neuron-specific splicing factor nSR100/SRRM4 regulates inclusion of most 
mammalian neural microexons (Irimia et al., 2014). While the functional significance for the 
majority of these microexons has yet to be demonstrated, the ones that have been described, 
including the N1-Src microexon, play critical roles in various aspects of neuronal development, 
such as neurite elongation, axon morphogenesis and guidance, and neurogenesis (Kotani et 
al., 2007; Leung et al., 2015; Keenan et al., 2017; Lewis et al., 2017).  
1.3: The Src family of non-receptor kinases 
N1-src is a neuronal specific isoform of the Src proto-oncogene, the founding member of Src 
family kinases (SFKs) (Mustelin, 1994). The 11 members of the SFK family include Src, Fyn, 
Yes, Blk, Yrk, Frk, Fgr, Hck, Lck, Srm, and Lyn (Parsons and Parsons, 2004). SFKs have roles 
in the regulation of key signaling pathways involved in cell fate specification, cancer and 
development. Most cells in vertebrate organisms express at least one SFK, with some 
expressing multiple isoforms of the same protein (Thomas & Brugge, 1997). SFKs interact with 
many cellular cytosolic, nuclear and membrane proteins, modifying these proteins by 
phosphorylation of tyrosine residues. This multifunctionality stems from the conserved modular 
structure that is shared by all family members (Figure 2). SFKs comprise six distinct functional 
regions: the myristoylated N-terminal membrane-targeting Src homology 4 (SH4) domain, the 
SH3, SH2 and tyrosine kinase (SH1) domains and a short C-terminal tail (Engen et al., 2008). 
SH3 and SH2 domains bind proteins at polyproline peptide (PXXP) motifs and phosphotyrosine 
motifs respectively (Arold et al., n.d.). Potential substrates containing these motifs may bind, 
relocate and activate Src. The C-terminal tail of Src contains a conserved tyrosine residue that 
acts as an autoinhibitory phosphorylation site (Y527), bound by its SH2 domain when 




Figure 2. Domain structure of v-Src, c-Src, and Neuronal Src proteins.  
The conserved Src-homology domains of Src family kinases are depicted, together with the 
positions of regulatory phosphorylation sites. v-Src has a shorter C-terminal domain that 
lacks the autoinhibitory phosphorylation site (Y527).  Adapted from (Wetherill, 2016)  
 
The ligand-binding surfaces of SH3 and SH2 not only confer substrate specificity, but are also 
involved in low-affinity intramolecular interactions that regulate the transitions of the protein 
between active and inactive states (Xu et al., 1999). Situated between the SH4 and SH3 
domains is the ‘unique’ domain (UD), an intrinsically disordered region. Recent evidence 
shows that a fuzzy interaction between a UD of one Src partner in its open active conformation 
with a kinase domain of a second partner is required for Src dimerisation (Spassov et al., 
2018). Dimerisation allows Src to bind to membranes much stronger by simultaneously 
inserting two myristoyl chains. Moreover, i enhances autophosphorylation of Y416 and 
consequently Src kinase activity. Therefore, shifting between monomeric and self-associated 
states provides another level of regulation of Src signalling (Le Roux et al., 2016).  
1.4: Cellular Functions of C-Src 
Due to functional redundancy between Src family members and their multiple isoforms, 
identification of the specific role of each Src family kinase is very difficult. However, C-Src is 
the most studied SFK with many known functions in different cellular processes including gene 
transcription, cell adhesion and migration, cell cycle progression and apoptosis. The 
involvement of C-Src in such a variety of pathways reflects a requirement for its intricate spatial 
and temporal regulation. Src’s flexible protein domains in conjunction with myristoylation can 
determine its subcellular localization by mediating attachment to different cellular membranes. 
In its resting state, C-Src is associated with endosomal membranes near the perinuclear 
microtubule-organizing center (Kaplan et al., 1992), and is delivered to the cytoplasmic side of 
the plasma membrane upon stimulation (Sandilands et al., 2004).  At the plasma membrane, 
























Src is involved in receptor-induced signal transduction pathways. Receptor clustering or 
dimerization leads to activation and recruitment of Src to the receptor complexes where it 
phosphorylates the tyrosine residues within the receptor cytoplasmic domains. For example, 
phosphorylation of epidermal growth factor (EGF) receptor clathrin heavy chain is required for 
its internalisation (Wilde et al., 1999). Subcellular localisation of Src can affect its function. C-
Src activity causes RhoA inhibition at focal adhesion sites (Thomas and Brugge, 1997), but 
activation of the same protein at podosomes (Berdeaux et al., 2004).  Within the nucleus, Src 
is thought to help regulate the cell cycle and cell division by its interactions with other proteins. 
For example, Src phosphorylates Sam68 (Src-Associated substrate in Mitosis of 68 kDa) 
during mitosis thereby changing binding ability and specificity of Sam 68-RNA interactions 
(Taylor et al., 1995).  This prepares Sam68 for interaction with G1-specific messages and 
promotes exit from mitosis (Pillay and Nakano, 1996). The activation of C-Src leads to the 
promotion of survival, proliferation, adhesion and invasion pathways, like the RAS-MAPK and 
PIK3-Akt signalling pathways. Since uncontrolled growth is a necessary step for the tumour 
development and progression; mutations that result in increased activity or overexpression of 
C-Src have been implicated in a number of human cancers (Dehm and Bonham, 2004; 
Ishizawar and Parsons, 2004). c-Src is a proto-oncogene, a normal gene that becomes an 
oncogene due to aberrant expression, whereas its viral homologue encoded by Rous sarcoma 
virus, v-Src was the first discovered oncogene (Martin 2001). It lacks the C-terminal inhibitory 
phosphorylation site (Y527), and is therefore constitutively active as opposed to C-Src, which 
is only activated under certain circumstances where it is required (Figure 2, Smart et al., 1981). 
Before the discovery of the Src gene in chickens, cancer was thought to only be caused by 
foreign agents, viruses.  
1.5: C-Src Functions in the Brain 
Although expressed ubiquitously, maximal c-Src expression levels are 5–200-fold higher in 
platelets, neurons and osteoclasts than in other tissues. Early studies of Src expression in the 
developing rat brain revealed that its peak expression and activity correspond to neurogenesis 
and neuronal growth (Cartwright et al., 1988). Since then C-Src has been implicated in multiple 
processes in neuronal development. Discovery of alpha and beta-tubulin as major Src 
substrates in growth cone membranes provided evidence for its role in neurite outgrowth 
(Matten et al., 1990). C-Src function in the brain is also regulated by receptor-induced signal 
transduction.  Cell adhesion receptors, in particular L1-CAM, control C-Src activity during 
neurite outgrowth (Beggs et al., 1994; Ignelzi et al., 1994)  
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1.6: Neuronal Srcs  
Studies on the expression of C-Src in rat and chick embryos had indicated that neural tissues 
contain elevated levels of a form of a Src protein that was structurally distinct from C-Src 
expressed in non-neuronal cell cultures (Brugge et al., 1987). It was later revealed that two 
neuronal splice variants of Src, N1- and N2-Src, exist in mammals and birds, which contain a 
6 and 17 amino acid insert in their SH3 domains respectively (Levy and Brugge 1989; Pyper 
and Bolen, 1990). The 6 aa insert (RKVDVR) in the N1-Src protein results from a single 
microexon inclusion between exons 3 and 4 of c-Src, which is repressed in nonneuronal cells 
by PTBP1 binding to the repressor elements in the N1 microexon 3′ splice site and in the 
downstream intron (Figure 3, Chan and Black, 1997; Chou et al., 2000). PTBP1 blocks the 
interaction of the U1 snRNP with U2AF and, thus, prevents assembly of U2AF at the 
downstream 3′ splice site (Sharma et al. 2005). In addition to the PTBP-binding sites that 
surround the N1 exon, there is a strong UGCAUG enhancer in the downstream intron that is 
recognised by RBFOX proteins and promotes N1 inclusion. There are multiple additional cis-
elements that affect N1 splicing, including binding motifs for hnRNP A1 in the exon and for 
hnRNP H in the downstream intron (Chou et al., 1999; Rooke et al., 2003).  
 
Figure 3. Regulation of alternative splicing of the Src N1 microexon.  
The N1 microexon is repressed in non-neuronal cells by polypyrimidine tract-binding protein 
(PTB), which binds to repressor elements in the N1 3′ splice site and in the downstream 
intron, blocking the assembly of the spliceosomal complex. RBFOX proteins bind to 
enhancer elements in the intron downstream from N1 to stimulate its splicing. In neurons the 
N1 exon codes for a six amino acid insert in the n-Src loop of the substrate binding SH3 
domain. Adapted from (Keenan et al., 2015).  
 
The residues encoded by the N1 microexon affect SH3 domain substrate specificity of N1-
Src (Keenan et al 2015).  Furthermore, N1-Src has an enhanced constitutive  kinase  activity 
due to a loss of an intramolecular interaction of the SH3 domain with the SH2-kinase linker 
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(Brugge et al. 1987; Martinez et al. 1987; Keenan et al. 2015). N1-Src is highly active during 
neural development with its levels showing a 8-to 20 fold increase in an embryonal 
carcinoma (EC) cell line after treatment with retinoic acid (RA), which drives differentiation of 
EC cells into neuron-like cells that grow neurite-like processes and express neuronal markers 
(Lynch et al., 1986). Expression of constitutively active N1-Src in a transgenic mouse under 
the control of the L7 Purkinje cell promoter, affected the assembly of microtubules, causing 
aberrant dendritic morphogenesis (Kotani et al., 2007). Interestingly, both knockdown and 
overexpression of N1-Src inhibited neurite elongation in cultured neurons (Keenan et al., 
2017). The potential mechanism underlying this effect could be due to N1-Src increased 
catalytic activity which could lead to aberrant substrate phosphorylation and formation of 
promiscuous ligand interactions upon overexpression. Investigations by (Wetherill, 2016; 
Keenan et al., 2017) into the role of N1-Src in neurite outgrowth suggested that it acts in L1-
CAM and RhoA signalling pathways. The data implied that constitutive activation of RhoA 
prevented N1-Src mediated process elongation, however N1-Src did not promote process 
outgrowth via the inhibition of RhoA. (Wetherill, 2016) proposed that N1-Src overexpression 
enhances RhoA activation, therefore self-regulating via a negative feedback loop.  
1.7: N1-Src and neuroblastoma 
Despite Src having known roles in promoting cancer development and progression, N1-Src 
has been implicated as a positive prognostic indicator in neuroblastoma, a childhood cancer 
caused by the failure of certain neural crest cells to differentiate along the parasympathetic 
lineage (Tomolonis et al., 2018). It exhibits a high level of clinical and genetic heterogeneity 
with the course of disease ranging from spontaneous regression without any required medical 
intervention to treatment-resistant tumour progression, metastasis and death (Brodeur, 2003). 
Despite extensive sequencing efforts, only a few recurrent somatic mutations have been 
identified (Chen et al., 2015).  
All patients with metastatic/Stage 4 disease diagnosed after one year of age or those with an 
amplification of the MYCN gene are classified as high-risk. High-risk neuroblastoma patients 
have only a 40% likelihood of survival (Maris and Matthay, 1999). They are typically treated 
with multimodal therapy, including high-dose chemotherapy, surgical resection, radiation 
therapy, bone marrow transplantation, and retinoic acid (RA). RA has been shown to induce 
growth arrest and differentiation of human neuroblastoma cells (Hämmerle et al., 2013; 
Janesick et al., 2015). It is used to prevent relapse, however the responsiveness to RA therapy 





A high N-Src to C-Src ratio is a positive prognostic marker in neuroblastoma with N-Src being 
highly expressed in infant cases, which tend to have a good prognosis (Bjelfman et al., 1990). 
Additionally, N1-Src mRNA is highly expressed in neuroblastoma cell lines with the ability to 
differentiate but not in the cell lines lacking the capacity to mature in response to RA, 
irrespective of MYCN gene amplification and overexpression (Matsunaga et al., 1993). Exon 
array and CHIP-Seq analysis identified an alternative splicing programme in Stage 4 
neuroblastoma tumours mediated by MYCN binding to promoter regions of the splicing factors 
PTBP1 and HNRNPA1, leading to their overexpression and poor survival in high risk patients 
(Guo et al., 2011; Zhang et al., 2016a). Splicing inhibitors that are being developed as anti-
cancer agents might represent an excellent therapeutic for neuroblastoma by mimicking the 
events that occur in normal differentiation of the neural crest cells. Interestingly, data from 
(Lewis et al., 2017) suggests that N1-Src is expressed at low levels in adult Xenopus heart 
tissue. N1-Src has also been found in back muscle cells of chick embryos at early stages of 
development.(Atsumi et al., 1993) This might be due to neural crest cells that migrate from the 
neural tube to the heart and back to form cardiac and striated muscle tissue there.     
1.8: A role for N1-Src in Xenopus primary neurogenesis 
Xenopus is one of the major model systems for the study of vertebrate embryogenesis. There 
are multiple advantages to the use of Xenopus as an experimental system, such as the 
availability of large abundant eggs that are easily manipulated and the striking synteny 
between the frog and human genomes (Amin et al. 2014). Even though neuron- specific 
splicing appears to be a feature of higher animals, frogs also have a neuronal splice variant of 
C-Src but it has only a 5 amino acid insert instead of the 6 amino acids seen in other organisms. 
The distribution of charged and hydrophobic residues contained within the insert is retained 
and it has been shown that the activity of mammalian and Xenopus n1-src is conserved.  
In frogs, as in other lower vertebrates, an initial wave of neurogenesis gives rise to a simple 
pattern of primary neurons (Henningfeld et al. 2007). This process of primary neurogenesis is 
used as a model for the study of mechanisms involved in neural cell fate decisions. During that 
process the balance in activity of proneural and neurogenic genes selects individual cells in 
the dorsal ectoderm for differentiation into neurons (Bertrand et al. 2002). Neurogenesis can 
be tracked by monitoring the expression of a neuronal-specific tubulin (tubb2a). N1-Src 
knockdown by  splice site-blocking morpholinos in X.tropicalis embryos maintains C-Src 
expression but inhibits primary neurogenesis, as indicated  by a reduction in tubb2a-positive 
neurons (Lewis et al., 2017). This suggests that apart from regulating the activity of proteins 
involved in neuronal architecture, adhesion and morphogenesis, N1-Src has an earlier role in 
regulating the expression of genes essential for the transition of vertebrate neural progenitors 
to differentiated neurons. This is supported by the fact that n1-src expression is highly 
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regulated throughout early frog development, unlike C-src, whose expression is relatively 
constant during that time (Collett and Steele 1993). Unpublished proteomic and 
phosphoproteomic data from the Evans lab (Lewis et al., 2017) indicates that N1-Src interacts 
with and phosphorylates a subset of splicing factor proteins.   
1.9: Src and splicing during neurogenesis  
Early functional studies indicated that Src regulates pre-mRNA processing by tyrosine 
phosphorylation (Gondran and Dautry, 1999). Phosphoproteomic mass spectrometry and 
transcriptomic RNASeq data obtained in the Evans and Isaacs labs support those findings and 
suggest that N1-Src regulates a programme of alternative splicing during neuronal 
differentiation. Interestingly, preliminary in silico analysis suggests that putative tyrosine 
phosphorylation sites are specifically enriched within trans-regulatory factors as compared to 
the core splicing machinery. Taken together, Src phosphorylation is likely to impact the 




As stated above normal neural differentiation is subject to a tightly controlled splicing 
programme, which if disrupted can lead to neurodevelopmental disorders and cancer. 
Preliminary data from the Evans and Isaacs labs have led to the hypothesis that N1-Src 
regulates splicing in neurogenesis and this is at the level of the splicing of splicing factor 
genes. The overarching aim of this study was to test this hypothesis through the bioinformatic 
analysis of publicly available human and frog transcriptomic datasets. These datasets were 
subjected to a variety of approaches, including analysis of alternative splicing, functional 
clustering of gene sets, classification of splicing events and seeking mechanistic insight by 
searching for RNA binding protein motifs at splice junctions. The specific aims were: 
 
i) Discover if Src is a conserved regulator of the splicing of splicing factors. This was 
addressed by analysing differential alternative splicing in an RNAseq dataset from an inducible 
v-Src expressing cell line. 
 
ii) Establish if the splicing of splicing factor genes is a feature of normal neuronal development. 
Here, various RNAseq time-series from dissected tissues during normal Xenopus embryo 




iii) Gain insight into how N1-Src regulates splicing during neurogenesis. Finally, our preliminary 
RNAseq dataset from N1-Src knockdown Xenopus embryos was analysed to discover if 






Chapter 2: Methods 
2.1: RNA-seq datasets and genome assemblies 
All publicly available RNA-Seq datasets used in the current study are listed in Table 1.  
Datasets used to address aims: 
i) Ji et al. 2019 described the gene regulatory network and the transcriptional changes during 
transformation in a MCF10-ER-Src cell line model of breast cancer. A single-end library was 
constructed followed by RNA-Seq using the Illumina HiSeq 2000 system.  
ii) Session et al. have used high throughput sequencing to study the evolution of gene 
expression in X.laevis. mRNA for sequencing was extracted at 14 developmental stages and 
poly(A) enriched for mRNA in duplicate. For each timepoint, high throughput sequencing was 
performed using Illumina HiSeq 2000 with paired-end library preparation. Peshkin et al. 2015 
measured mRNA levels across 18 developmental stages to characterise the relationship 
between coding RNA and protein dynamics during X.laevis differentiation. Two separate 
methods of mRNA extractions were used: poly(A) enrichment and ribosomal RNA (rRNA) 
depletion, therefore producing no technical replicates. This study used HiSeq 1000 for 
sequencing. Similarly to Session et al, Tan et al. 2013 used poly(A) selected mRNA to prepare 
a paired-end library followed by sequencing with HiSeq 2000 to characterize the transcriptome 
dynamics during X.tropicalis development. Using a paired-end mRNA library and the Illumina 
HiSeq 2000, Plouhinec et al., 2017 provided RNA sequencing data profiling the transcriptomes 
of X.laevis ectodermal domains at 2 stages of embryo differentiation.   
iii) A.Pizzey of the Evans and Isaacs labs used short-read RNASeq of mRNA from N1-Src 
knockdown and control X.tropicalis embryos to investigate the role of N1-Src in vertebrate 
neurogenesis. For the Illumina RNA-Seq library, the NEBNext Poly(A) mRNA Magnetic 
Isolation Module was used to isolate Poly(A) mRNA from total RNA. After a paired-end cDNA 
library construction, transcripts were sequenced on an Illumina HiSeq 3000 machine.  
 
GENCODE hg38 transcript annotations were used for transcript quantification in the MCF10-
ER-Src cell line.  Ensembl Xenopus_tropicalis_v9.1 and UCSC Xenopus_laevis_v2 
assemblies and gene annotations were used for the Xenopus dataset analysis.  
 
The list of putative c-Src and N1-Src phosphorylation substrates was collated from the results 
of bioinformatic analysis by James Ormond (unpublished MSc dissertation) and LC-MS/MS 
phosphoproteomic data (West, 2019).  
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2.2: Data preprocessing  
All fastqc files downloaded from Gene Expression Omnibus (GEO) using axel were quality 
checked with FastQC. TrimGalore (Martin, 2011) was used to remove adaptors and low-
quality reads. Adapter contamination could cause the reads that share maximal exact 
matches to fail to align within the required score threshold. Trimmed reads were then either 
aligned to the genome using HISAT2 (Pertea et al., 2016) or passed straight to Salmon 
(Patro et al., 2017) for transcript quantification using the following code.: 
 
for i in *_1.fastq.gz 
do 
   prefix=$(basename $i _1.fastq.gz) 




The --validateMappings flag is used for the selective alignment approach. The whole 
reference transcriptome and genome were used as a decoy sequence for the index used in 
quantification in mapping-based mode. This was done to avoid reads coming from a novel 
locus that are similar with annotated transcripts from being false mapped to the reference.  k-
mers of length 31 were used for all datasets, except the MCF10-ER-Src, where k-mers of 
length 29 were used, due to reads being 50bp long instead of 100.  
 
For the X.laevis datasets, the trimmed and quality checked reads were aligned to the 
genome with HISAT2 and then the output SAM files were converted to BAM, sorted by their 
genomic location and indexed with SAMtools (Li et al. 2009). These BAM files were 
visualised using IGV (Robinson et al. 2011) and passed to StringTie, which assembles and 
quantifies the transcripts in each sample. The assembled transcripts and the reference gene 
annotation GTF files were merged together by the StringTie --merge module, which created a 
non-redundant uniform set of transcripts for all samples. The newly assembled transcriptome 
was then used as a reference for Salmon transcript quantification. In the case of human and 
X.tropicalis files, the alignment and transcriptome assembly steps were skipped as the 
transcriptome is well-annotated.   
2.3: Differential splicing analysis  
All the datasets were analysed with SUPPA (Trincado et al. 2018) psiPerEvent module to 
obtain the percent-spliced-in (PSI) value for each AS event. PSI represents the fraction of 
transcripts that have the exon inclusion. It is calculated as the ratio between the reads 
supporting the inclusion of the exon and the total number of reads attributed to that event, 





𝑒𝑥𝑐𝑙𝑢𝑠𝑖𝑜𝑛	𝑟𝑒𝑎𝑑𝑠	 + 	𝑖𝑛𝑐𝑙𝑢𝑠𝑖𝑜𝑛	𝑟𝑒𝑎𝑑𝑠 	× 	100 
Each type of event was defined by a unique set of genomic coordinates around the splice 
site. For exon skipping events, the start and end coordinates for the different exonic regions 
involved in the event; the external coordinates of the event were only used for the intron 
retention and alternative first exon events. 
The SUPPA diffSplice module was then used for DS analysis. The chromosome coordinates 
of differential AS events considered significant at p <= 0.1, |dPSI < 0.1| were then extracted 
with R.  
VAST-TOOLS (Tapial et al. 2017) was then used for the human and X.tropicalis datasets. 
Following genome alignment with the vast-tools align module, the output files from the 
MCF10-ER-Src dataset were pulled together with the vast-tools merge module to 
compensate for low read coverage. The diff module was then used for differential AS 
analysis. VAST-TOOLS uses bowtie to align reads and provides both cRPKM and PSI 
values. Vertebrate Alternative Splicing and Transcription Database (VastDB) that is used for 
DS quantification does not offer annotations for X.laevis so this tool could not be used for this 
species data analysis. 
The heatmaps were constructed using Heatmapper, an interactive web-based tool (Babicki et 
al., 2016). Z-scores (the number of standard deviations by which the value of a raw PSI is 
above or below the mean PSI) were plotted instead of normalized PSI values and are 




Z = Z-score 
x = observed value  
𝜇 = mean of the sample 
𝜎 = standard deviation of the sample 
 
The Z-scores are computed after the clustering, so that it only affects the graphical 
aesthetics. For the RNA processing heatmaps annotated genes within the GO term class 
“RNA processing” (GO:0006396) were considered as “regulators of RNA processing”. “RNA 
processing” contains the “RNA splicing” class within itself. It was chosen due to some RBPs 
having proposed but unconfirmed roles in RNA splicing.  
2.4: Motif enrichment analysis  
 
The SUPPA significant splicing change file was split by event type. Chromosome coordinates 
of sequences that were 150 nt upstream and downstream of splice sites involved in each type 
of splicing event were extracted using one of the scripts provided as part of the MoSEA 
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pipeline (Trincado et al., 2018). bedtools (Quinlan and Hall, 2010) was used to convert those 
coordinates to a FASTA file. Motif enrichment analysis of the sequences was then performed 
using AME (McLeay and Bailey 2010; MEME Suite), with statistical analysis by one-tailed 
Fisher’s exact test. AME identifies known user-provided motifs that are enriched in the 
sequences of interest compared with control sequences. A motif was considered significantly 
enriched at E-value < 10, p <= 0.05. Shuffled input sequences were used as a control as it 
preserves the GC content and k-mer frequency. The MEME feature ‘fasta-unique-names’ was 
used to append the duplicate number “_i” after any duplicate sequence names that arose, to 
account for two separate events of the same class occurring in one gene. Position weight 
matrices of the motifs from the CISBP-RNA (Catalog of Inferred Sequence Binding 
Preferences of RNA binding proteins) database (Ray et al., 2013) were used for this project. 
Matt (Gohr and Irimia, 2019) was used to produce motif RNA maps for all CISBP-RNA IUPAC 
binding motifs with a sliding window of length 31 nt, which slides up to position 35 nt into exons 
and up to position 135 nt into introns. Events were discarded if they did not pass the VAST-
TOOLS VLOW threshold of ≥20/15/10 actual reads mapping to the sum of exclusion splice 
junctions. Below is the code used for implementing Matt: 
 
matt get_vast $vts_file -complex IR,IR-S,IR-C -a Tam -b Ctrl -minqab VLOW -minqglob N -gtf $gtf -f gene_id > 
gencode_IR.tab 
matt get_vast $vts_file -complex S,C1,C2,C3,MIC -a Tam -b Ctrl -minqab VLOW -minqglob N -gtf $gtf -f 
gene_id > gencode_SE.tab 
matt def_cats gencode_SE.tab GROUP 'silenced=DPSI_GRPA_MINUS_GRPB[15,100]' 
'enhanced=DPSI_GRPA_MINUS_GRPB[-100,-15]’ 'unregulated=DPSI_GRPA_MINUS_GRPB[-1,1] 
PSI_Ctrl[10,90]' | matt add_cols gencode_SE.tab - 
matt rna_maps_cisbp gencode_SE.tab UPSTRM_EX_BORDER START END DOSTRM_EX_BORDER SCAFFOLD 
STRAND GROUP[silenced,enhanced,unregulated] 31 35 135 $fasta cisbprna_regexps -d $output_dir 
 
The Src-regulated TRA2A intron retention event chromosome coordinates pulled from the 
VAST-TOOLS diff output were inserted into oRNAment (Benoit Bouvrette et al., 2020) for 
interactive visualisation of RBP binding motif instances.  
2.5: Functional enrichment analysis  
Functional enrichment analysis was performed according to Reimand et al., 2016 using the 
functional enrichment analysis tools g:Profiler (https://biit.cs.ut.ee/gprofiler) and GSEA 
(https://www.gsea-msigdb.org/gsea/). Structured controlled vocabularies from Gene 
Ontology, as well as information from the curated KEGG and Reactome databases were 
included in the analysis. Only functional categories with more than three members and fewer 
than 800 members were included in the analysis. Significance was assessed using the 
hypergeometric test with multiple testing correction by the Benjamini and Hochberg method. 
The Cytoscape plug-in Enrichment map (http://baderlab.org/Software/EnrichmentMap) 
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(Isserlin et al., 2014) was used to visualize and arrange functional data. Genes selected for 
Gene Ontology enrichment analysis were those appearing to be showing significant 
alternative splicing changes according to at least two of the four tools used.  
2.6: Event clustering  
The SUPPA clustering module was used to calculate the clusters of events according to PSI 
values across conditions. SUPPA uses density-based spatial clustering (DBSCAN; 
(Pedregosa et al., 2011) which clusters events that might not have similar PSI values within 
the same samples, but behave similarly across conditions.  
2.7: Differential gene expression analysis 
Differential gene expression was quantified using Sleuth version 0.29.0. Estimates of 
transcript abundances (Salmon) were normalized to gene length for gene level analysis.   
2.8: Summary of software and algorithms used in this study 
AME (McLeay and Bailey, 2010) https://meme-suite.org/meme/tools/ame 
TrimGalore - http://www.bioinformatics.babraham.ac.u
k/projects/trim_galore/ 
g:Profiler (Reimand et al., 2016) https://biit.cs.ut.ee/gprofiler 
Cytoscape – 
Enrichment map 
(Isserlin et al., 2014) http://baderlab.org/Software/EnrichmentM
ap 
HISAT2 (Kim et al., 2019) http://daehwankimlab.github.io/hisat2/ 




Salmon (Patro et al., 2017) https://combine-lab.github.io/salmon/ 
Sleuth (Pimentel et al., 2016a) https://pachterlab.github.io/sleuth/ 
SUPPA2 (Trincado et al., 2018) https://github.com/comprna/SUPPA 
3DRNASeq (Guo et al., 2019) https://3drnaseq.hutton.ac.uk/app_direct/
3DRNAseq/ 
GSEA (Subramanian et al., 2005) https://www.gsea-msigdb.org/gsea/ 
axel - https://github.com/axel-download-
accelerator/axel 
VAST-TOOLS (Tapial et al., 2017) https://github.com/vastgroup/vast-tools 
Matt (Gohr and Irimia, 2019) http://matt.crg.eu/ 
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Heatmapper (Babicki et al., 2016) http://www.heatmapper.ca/ 




Chapter 3: Results 
The central hypothesis of this study arose from unpublished work by Alastair Pizzey in the 
Evans and Isaacs labs  in which short and long-read RNA-Seq analysis was performed on 
Stage 14 X. Tropicalis embryos injected with control or N1-Src antisense morpholinos 
(described in Pizzey’s PhD thesis, unpublished). Preliminary differential splicing analysis using 
DEXseq  (Anders et al. 2012) identified perturbed splicing in splicing factor genes in N1-Src 
knockdown X.tropicalis embryos. Bioinformatic analysis by James Ormond (described in 
Ormond’s MSc dissertation, unpublished) suggests that multiple splicing factors contain 
putative Src tyrosine phosphorylation sites, which interestingly are specifically enriched within 
trans-regulatory factors as compared to core splicing machinery. Furthermore, proteomic and 
phosphoproteomic analyses in the Evans lab identified splicing factors as SH3 domain binding 
partners and substrates of N1-Src (West 2019). 
 
To gain insight into whether N1-Src regulates splicing factor gene splicing in normal neuronal 
development and the mechanism responsible, several relevant publicly available RNA-seq 
datasets were identified.  These datasets (Table 1) were selected to address the role of Src in 
regulating splicing and the role of splicing factor gene splicing in neuronal development and 
differentiation. 
 
Table 1: Questions addressed and the datasets used in this thesis  
Aim Model system RNASeq Data  Source 





Human cancer cell 
line (MCF10A-ER-
Src) where v-Src 







(Ji et al., 2019) 
2. Is splicing an 
important aspect 




Whole X. laevis 
embryos at different 
developmental 
stages 
Stages 10, 13-14, 
20 (3 technical 
and biological 
replicates) 
GEO accession:  
GSE73430; GSE73905 
(Session et al., 2016); 
(Peshkin et al., 2015) 
Whole X.tropicalis 
embryos at different 
developmental 
stages 





(Tan et al., 2013) 
X. laevis ectodermal 
sections at different 
developmental stages  
Stages 12.5, 14 





(Plouhinec et al., 2017) 
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X.tropicalis Stage 14 
embryos where N1-
Src is knocked down 
Control MO vs 
N1-Src AMO 
(Stage 16) 
(Pizzey, PhD thesis, 
unpublished) 
(Lewis et al., 2017) 
 
3.1 Developing a data analysis pipeline to process RNA-Seq datasets for alternative 
splicing 
RNA-Seq data analysis started with the development of a pipeline (Figure 4) that could 
provide useful insights into differential splicing changes happening between stages in a 
developmental time series or between conditions in a human cell line. The pipeline included 
quality control and pre-processing of the raw data, followed by transcript quantification and 
finally, DS analysis and RBP motif enrichment.  
 
As mentioned above, this work has been motivated by findings from experiments in 
X.tropicalis. However, in order to provide enough replicates for the statistical analysis that is 
carried out as part of multiple steps of this pipeline, data from a related tetraploid species, 
X.laevis, was used to address some of the questions. Due to X.laevis being a less well-
annotated organism, additional steps involving genome alignments and guided transcriptome 
assembly were added. Aligning to a reference transcriptome rather than to a genome is 
usually faster and requires less computational power. However, it fails to recognise 
unannotated novel transcripts or intron retention, which is relevant in the case of studying 
alternative splicing in an organism with a less well-annotated transcriptome. Therefore, 
trimmed and quality checked X.laevis reads were aligned to the genome with a fast splice-
aware aligner HISAT2. Prior to processing these newly aligned reads with Stringtie, they 
were indexed and sorted with SAMtools and the resulting BAM files were loaded onto IGV to 
be visualised. Stringtie was then used to produce a reference guided transcriptome 
assembly. Gene abundance files from Stringtie turned out to not be compatible with most of 
the downstream AS and gene expression analysis tools. Therefore, to avoid an additional 
format adjusting step, Stringtie was only used for X.laevis transcriptome assembly and 
Salmon was used for all transcript quantification. This also led to the use of a consistent 
transcript quantification method for all datasets.  
3.1.1. Differential splicing analysis 
 
Multiple DS tools were considered and then selected for the analysis after confirming 
previous observations that showed that different tools perform significantly differently across 
different datasets or numbers of samples (Mehmood et al., 2019). There are currently three 
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major categories of methods used by splicing analysis tools: exon-based, isoform-based or 
event-based. Exon- and event-based methods fall into one overarching category of event-
based methods, that calculate the number of sequencing reads falling on each counting unit, 
which can be exons or exon junctions. The isoform-based methods reconstruct the full-length 
transcripts before AS analysis and are useful for biological interpretation when the focus is on 
specific genes with known functional implications of changes in expression of particular 
isoforms. However, after running preliminary analyses using different types of tools, event-
based methods were favoured. Their output is easier to interpret as they report on types of 
AS event and the aim of this project was to look at general trends in splicing events rather 
than effects on specific transcripts.  
The first event-based method selected was SUPPA (Trincado et al., 2018), which quantifies 
splicing events themselves by calculating the PSI values for each event, which measures the 
fraction of mRNAs expressed from a gene that contains that event. SUPPA uses transcript 
abundances determined with Salmon to estimate the PSI values for each of the four standard 
types of splicing events: alternative 3’ splice site, alternative 5′ splice site; intron retention, 
and exon skipping, in addition to two other event types, alternative first exon (AF) and 
alternative last exon (AL). It can only perform pairwise differential AS analysis, however it can 
quantify the PSI values in multiple conditions, which is useful for time-series data. It also has 
a much lower false positive rate than other DS methods, especially at shorter read lengths.  
The second tool selected was 3DRNA-seq (Guo et al., 2019), an R Shiny app selected for its 
user-friendly interface and use of Salmon transcript abundance files as input. 3D RNASeq 
performs differential AS analysis with limma (Ritchie et al., 2015), an exon-based method that 
fits a linear model to the exon-level counts from Salmon and then tests for differential exon 
usage. Finally, the exon-level statistics are converted to gene-level test statistics to identify DS 
genes. The limitation of this approach is that unlike SUPPA, it does not infer the type of the 
splicing event occurring in a gene but only identifies the differentially expressed exons/ 
transcripts between experimental conditions. limma can also be used for differential gene 
expression analysis. A custom Python script was used to extract gene and transcript IDs from 
gene annotation gtf files for 3DRNASeq analysis.  
A few other DS tools were considered, including DICESeq (Huang and Sanguinetti, 2016) 
which uses HISAT BAM alignment files to estimate the changes in isoform proportions from 
time series RNA-seq experiments. This tool was the perfect candidate for developmental 
stages analysis, however potentially due to the code being inefficient, the script would run for 
days only to be terminated for an unknown reason.  
Finally, VAST-tools (Tapial et al., 2017) that was initially disregarded for only being 
compatible with data from a small number of model organisms. It was re-evaluated due to its 
ability to detect microexon splicing and compatibility of its output with Matt, a toolkit for 
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downstream analyses of AS which includes creation of RBP maps. The VAST-tools 
microexon module uses exon-exon and exon-microexon-exon junctions to specifically 
quantify short exons (3-15 nucleotides). The VAST-tools diff module (Tapial et al., 2017) 
allows testing for differential AS based on replicates and read depth for each event. It 
therefore allowed the use of the similarly disregarded X.tropicalis duplicate developmental 
series dataset. It also allowed for a more sensitive detection of AS events in the MCF10-ER-
Src dataset, where reads could be merged together to compensate for low read depth.  
None of the tools identified Src transcripts as being significantly spliced in the N1 exon 
knockdown dataset, potentially due to the exon being only 15 nucleotides long. However, the 
single splicing event SUPPA2 recognised for Src after knockdown was exon skipping, but the 
p-value was 0.0519, making it a non-significant event. Therefore, a less stringent arbitrary p-
value of 0.1 was selected for use with the less sensitive tools based on N1 exon skipping 
being a confirmed event. 
3.1.2. Motif enrichment analysis  
 
To explore the regulatory mechanisms involved in the developmentally and Src-regulated AS 
events, motif enrichment analysis was included in the analysis pipeline. Trincado et al. use 
their own motif scan and enrichment analysis (MoSEA) tool for the analysis of SUPPA2 
output. Sections of scripts used by MoSEA for extraction of relevant chromosome 
coordinates were applied to SUPPA output split by event type, to then be used as input for 
AME motif enrichment analysis.  
Figure 4. Data analysis pipeline. Flowchart of the optimised pipeline used to analyse RNA-
Seq datasets in this study. Each blue box describes the type of analysis performed and the 
relevant software packages are listed beside them.  
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3.2: v-Src expression regulates a programme of alternative splicing in a human 
MCF10-ER-Src cell line  
 
To determine if Src function in regulating alternative splicing is conserved in human cells, we 
selected expression data from a study where transient activation of viral Src (v-Src) was used 
to model oncogenesis (Ji et al., 2019). In this model, a non-tumorigenic human epithelial cell 
line (MCF10A) containing ER-Src, a derivative of v-Src that is fused to the ligand-binding 
domain of the estrogen receptor (ER), is treated with a partial ER agonist tamoxifen. 
Tamoxifen rapidly induces the transcriptional expression of the v-Src-encoding transgene, 
which in turn triggers a pro-inflammatory positive feedback loop that stably transforms the 
cell line and maintains it even after tamoxifen removal (Iliopoulos et al., 2009). The 
transforming abilities of v-Src come from it being constitutively active. The C-terminal domain 
of v-Src is truncated and lacks the regulatory Tyr527, the residue on the C-terminal tail that 
promotes autoinhibition upon its phosphorylation (Figure 2, Sefton and Hunter, 1986). 
Similarly to viral forms, neuronal splice variants of Src demonstrate increased catalytic 
activity compared to c-Src. Previous studies suggest that this is due to the neuronal exon 
insertion disrupting the interactions between the SH3 domain and the SH2 catalytic domain 
linker, which are required for Src autoinhibition (Arold et al., 2001; Brugge et al., 1987). 
Additionally, N1-Src activity is not affected by Tyr-527 phosphorylation (Brugge et al., 1987; 
Xu et al., 1999). This makes v-Src activation a good model for N1-Src kinase activity. 
 
The RNA-Seq data was produced using mRNA extracted from MCF-10A-ER-Src cells 24 h 
after treatment with 1 µM 4-hydroxy-tamoxifen or its vehicle, ethanol, as a control. The 
authors discuss the large scale effect that v-Src activation has on the activity of pro-
inflammatory transcription factor networks, chromatin structure and gene expression, 
however, they do not mention splicing. Unfortunately, during analysis of the data I discovered 
that the read depth was only really suitable for differential gene expression analysis and not 
splicing, as it would only be sensitive to changes in splicing of highly expressed genes. 
However, analysis with two AS algorithms vast-tools (Figure 5B) and SUPPA (Figure 5C) still 
revealed a range of splicing changes occurring as a result of Src activation. The vast-tools 
diff module is able to provide estimates if replicates are not available and therefore sample 
replicates were combined to compensate for low read depth. Four main AS patterns (Figure 
5D), including alternative 3′ and 5′ splice sites (Alt3 and Alt5, respectively), exon skipping 
(SE) and intron retention (IR), were examined, with SUPPA also quantifying alternative first 
exons (AF) and VAST-TOOLS - microexons (MIC). Alternative 5’ splice sites, also known as 
alternative donor sites, change the 3' boundary of the upstream exon, whilst alternative 3' 
splice sites change the boundary of the downstream exon. Splicing events with a cut-off of 
ΔPSI (change in average PSI) > 10 and p < 0.1 for SUPPA or p < 0.05 for VAST-TOOLS 
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were considered statistically significant (Figure 5A). Previous findings suggested that N1-Src 
regulates alternative splicing of splicing regulators themselves. Similarly functional 
enrichment analysis of differentially spliced genes revealed that along with gene ontology 
terms relating to regulation of cell cycle, DNA repair and tumour suppressor protein 53 
(TP53) regulated transcription which are relevant to cell transformation in cancer, RNA 
splicing and spliceosome were also two of most enriched terms (Figure 5E). The author 
attempted to investigate the correlation between the GO, KEGG, Reactome terms and the 
different clusters of exon skipping/ inclusion events in tamoxifen treated compared to control 
samples. However, due to being unable to extract useable lists of genes within the clusters, I 
was only able to produce a heatmap of differentially spliced exon events in genes falling in 
the GO term class “RNA processing” (GO:0006396, Supplementary figure1). 
As mentioned above, in silico screening by J. Ormond of phosphotyrosine sites within 
splicing factors revealed that many of them are SFK phosphorylation sites. This allowed us to 
suggest which SF proteins could be putative substrates of Src phosphorylation that would 
subsequently alter the splice pattern of transcripts of these splice factors and other 
transcripts (Supplementary Table 1). From that list, CLK2, DHX38, GEMIN5, KHSRP, 
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PLRG1, PRPF18, RBM25 and SRSF11 were differentially spliced after v-Src expression was 















































Figure 5. v-Src expression regulates a programme of alternative splicing in MCF10-ER-
Src cells.  
(A) Heatmap of differentially spliced exon events occurring between control and tamoxifen 
treated MCF10-ER-Src cells represented as Z-scores of percent-spliced-in(PSI) values, 
detected by VAST-TOOLS, with the corresponding hierarchical clustering. Due to low 
sequence coverage, reads from the GEO GSE115598 dataset were combined for differential 
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splicing analysis. B & C. Summary of classes of splicing events plotted as a % of total events 
according to VAST-TOOLS (B; 1761 total events) or SUPPA (C; 251 total events). 
Abbreviations: Alt3 - alternative 3’ splice site, Alt5 - alternative 5′ splice site; IR – intron 
retention, SE – exon skipping, AF - alternative first exon, MIC - microexon inclusion. (D) 
Diagrams of the four main classes of AS events. Blue boxes, flanking constitutive exons; 
orange boxes, alternative spliced exons/regions; solid lines, splice junctions supporting the 
inclusion isoform; dotted lines, splice junctions supporting the exclusion isoform. (E) 
Functional enrichment analysis of genes differentially spliced upon v-Src activation in 
MCF10A-ER-Src cells.  
 
One of the main aims of this project has been to describe the general trends in alternative 
splicing changes regulated by Src expression and make a link between the classes of 
regulated splicing events and the SFs that regulate them. Intron retention levels were hardest 
to evaluate due to different event-based tools having different approaches leading to varying 
strengths in identifying IR. Whilst some tools consider an intron retention event as significant 
as long as it is detected in one of the transcripts, SUPPA calculates the ratio of the 
abundance of transcripts that include the IR over the abundance of the transcripts that 
contain other forms of the splicing event. According to (Mehmood et al., 2019) despite 
SUPPA being able to detect the highest proportion of the qPCR-validated DS genes across 
the datasets compared to other tools, it only identified 8% of the qPCR-validated IR events, 
which is supported by the comparison with VAST-TOOLS performed in this study (Figure 
5B,C).  VAST-TOOLS reported intron retention to be the second most prevalent event type 
(722) in MCF10A-ER-Src cells after exon skipping (763), whilst SUPPA could only detect 8 
intron retention events. According to VAST-TOOLS, transcripts of 6 of the aforementioned 
putative Src substrates underwent intron retention, including CLK2, DHX38, KHSRP, PLRG1, 
RBM25 and SRSF11. VAST-TOOLS also discovered 3 microexon inclusion events.  
 
Figure 6. Diagram of splicing events highlights the sequence windows selected for the 



















Exons are shown as boxes and introns as lines. The retained/skipped section is shown in 
orange (Adapted from https://github.com/comprna/MoSEA) 
 
To investigate which potential SFs were regulated by v-Src expression, motif enrichment 
analysis of sequences surrounding the differential splicing events was carried out (Figure 6). 
To determine the factors that may preferentially regulate exon skipping events, motif 
enrichment analysis was carried out on the sequences surrounding the skipped exon 
junctions taking a 135 nt window into the neighbouring intron for MEME and Matt analysis 
(Table 2). MoSEA sequence selection script extracts the whole regulated exon sequence, 
whilst Matt only uses 35 nt on each end of the exon for its analysis. According to AME there 
were no significantly enriched RBP motifs in sequences relevant to intron retention and 
alternative 5’ splice site events at E-value < 10 and p <= 0.05. This can be explained by low 
numbers of events discovered for these classes by SUPPA. The only putative Src substrate 
enriched in all events was SRSF1. Unfortunately, this SR protein is necessary for all splicing 
reactions to occur and so is likely to be enriched at all exon boundaries. However, SRSF1 
can also influence splice selection and its regulatory impact of SRSF1 on splicing depends 
on its interaction with other splicing factors and its position in relation to the splice site 
(Anczuków et al. 2015). The results of the Matt analysis suggested that SRSF1 and SRSF9 
binding to regions in the exon leads to an upregulation of exon silencing or skipping. 
Whereas, binding of NONO, another putative Src substrate, in the upstream intron leads to 
exon inclusion or (Figure 7).  
 
Table 2. Consensus motifs of putative Src substrate SRSF1 are enriched at v-Src 
regulated splice junctions in a human cell line. RNA binding protein motif enrichment within 
a 135 nt window around the splice sites of differential splicing events occurring upon v-Src 
activation in MCF10A cells was calculated using AME (MEME Suite) one-tailed Fisher’s exact 
test (E-value < 10, p <= 0.05). Putative Src substrates are indicated in bold. The adj-p-value is 
the optimal enrichment p-value of the motif according to Fisher’s exact test, adjusted for 
multiple tests using a Bonferroni correction. The E-value is the adjusted p-value multiplied by 
the number of motifs in the motif file and represents the expected number of motifs that would 
be as enriched in the submitted sequences as this one. A total of 97 RBP binding motifs from 
the CISBP-RNA (DNA-encoded) database were examined. 
Event Motif RBP Consensus adj_p-value E-value motif_ID 
SE ELAVL2 HTYMTTTWTWTTY 2.03E-04 1.97E-02 M328_0.6 
SE IGF2BP3 AMAHWCA 9.74E-04 9.45E-02 M163_0.6 
SE HNRNPCL1 ATTTTTT 6.09E-03 5.91E-01 M158_0.6 
SE U2AF2 TTTTTYC 6.33E-03 6.14E-01 M077_0.6 
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SE RBM6 MATCCAR 1.54E-02 1.49E+00 M161_0.6 
SE ELAVL1 TTWTTTT 1.80E-02 1.75E+00 M031_0.6 
SE RALY TTTTTTG 3.05E-02 2.96E+00 M150_0.6 
SE CPEB4 YTTTTTT 3.25E-02 3.15E+00 M149_0.6 
SE PABPC4 AAAAAAA 3.38E-02 3.27E+00 M042_0.6 
SE TIA1 TTTTTTG 3.40E-02 3.30E+00 M075_0.6 
SE PABPC1 ARAAAAA 3.69E-02 3.58E+00 M146_0.6 
SE SART3 ARAAAAA 3.69E-02 3.58E+00 M062_0.6 
SE HNRNPC ATTTTTK 3.99E-02 3.87E+00 M025_0.6 
SE KHDRBS2 RATAAAM 4.71E-02 4.57E+00 M176_0.6 
SE EIF4B GTHGGAA 6.87E-02 6.66E+00 M290_0.6 
SE IGF2BP2 AMAWACA 6.93E-02 6.73E+00 M032_0.6 
SE FXR1 AAYGACRA 8.69E-02 8.43E+00 M152_0.6 
AF HNRNPL ACACACA 9.32E-06 9.04E-04 M027_0.6 
AF IGF2BP3 AMAHWCA 9.37E-06 9.09E-04 M163_0.6 
AF IGF2BP2 AMAWACA 3.40E-05 3.30E-03 M032_0.6 
AF ELAVL2 HTYMTTTWTWTTY 5.55E-04 5.38E-02 M328_0.6 
AF SRSF4 
(D.melanogaster) GGAGGGV 8.65E-03 8.39E-01 M126_0.6 
AF SRSF1 GGAGGAV 1.11E-02 1.08E+00 M102_0.6 
AF Fusip1 AGAGAAM 1.39E-02 1.35E+00 M019_0.6 
AF PABPC4 AAAAAAA 1.43E-02 1.38E+00 M042_0.6 
AF KHDRBS3 GATAAACV 3.06E-02 2.96E+00 M033_0.6 
AF BRUNOL5 TGTGTGT 3.45E-02 3.34E+00 M157_0.6 
AF RBM3 
(M.musculus) GTGTGTG 3.98E-02 3.86E+00 M049_0.6 
AF HNRNPH2 GGGAGGG 5.97E-02 5.79E+00 M151_0.6 
AF FXR1 AAYGACRA 8.80E-02 8.54E+00 M152_0.6 
Alt3 SRSF1 GGAGGAM 3.17E-02 3.07E+00 M102_0.6 





Figure 7. RNA splicing mapping reveals spatial enrichment of RNA binding motifs for 
SRSF1, SRSF9 and NONO across all exon skipping events.  
Right: Motif RNA-maps represented as percent of region covered by the motif within a sliding 
window of length 31 nt, which slides up to position 35 nt into exons and up to position 135 nt 
into introns for SRSF1 (A), SRSF9 (B) and NONO (C) with corresponding binding motif 
sequence logos where the y-axis represents bits of information (left). Exons are indicated as 
dark grey boxes. A total of 353 exons that passed the vast-tools VLOW threshold of 
≥20/15/10 actual reads mapping to the sum of exclusion splice junctions were considered, 
167629 events were discarded. Exon events fall into categories: silenced (downregulated 
exon inclusion, ΔPSI ≥15), enhanced (upregulated exon inclusion, ΔPSI ≤−15) and 
unregulated exons (|ΔPSI| ≤1).  
 
3.4: Splicing is an important feature of Xenopus early development.  
As previously described in Section 1.2, changes in splicing profiles of cells across 
developmental stages play an important role at different points in vertebrate neural 
development. To confirm that these specific splicing changes are an important aspect of 



















































across three stages of development covering neurogenesis were investigated. The 
X.tropicalis developmental time-series (GSE37452) was selected initially due to previous 
research on N1-Src in the lab being carried out using this organism. However, the dataset 
only included two biological replicates per stage, which was not enough for the statistical 
analysis carried out by splicing tools to define significant differences. Hence, the project 
shifted towards X.laevis, which is a related species with a sequenced genome. 
Developmental time series datasets of the X.laevis RNA-Seq short reads were available in 
NCBI GEO database under accession numbers GSE73430 and GSE73905 (Peshkin et al., 
2015; Session et al., 2016). The two datasets were combined to fulfil the need for triple 
repeats. In both datasets total RNA was collected from X.laevis J strain embryos according to 
the Nieuwkoop and Faber staging system. To allow for mRNA quantification, highly abundant 
ribosomal RNAs (rRNAs) must be removed from total RNA before sequencing. Peshkin et 
al., 2015 performed two distinct techniques to deal with rRNA: the first using poly(A) 
enrichment with oligo (dT) primers and the second using rRNA depletion, whilst Session et 
al., 2016 only used the poly(A) capture method. Sequencing was performed on Illumina 
HiSeq instruments producing 100-bp paired-end reads in both sets. In order to reduce 
technical variance between replicates, only the poly(A) set from GSE73905 was used.  
Stages 10, 15 and 25 were selected for analysis as they correspond to developmental events 
relevant to neurogenesis: gastrulation, start and end of neurulation. During neurula stages in 
Xenopus embryos, the ectodermal tissue undergoes its first differentiation into neural tissue, 
separating the neural plate from the ectoderm. This process of primary neurogenesis is 
regulated by N1-Src signalling (Lewis et al. 2017). Additionally, the datasets had the required 
number of RNA-Seq data replicates for these stages. Despite X.laevis being a model 
organism, it has a very poorly annotated transcriptome. This led me to create a new 
assembly using the genome assembly provided by NCBI, the splice-aware genomic 
alignment tool HISAT and the Stringtie assembler module. Upon learning that the X.tropicalis 
alternative splicing profile was included in the VastDB database, the X.tropicalis 
developmental data was analysed using VAST-tools. 
 
Expectedly, results showed large scale changes in splicing with exon skipping and alternative 
first exon usage being the most commonly occurring types. Only 10 differential splicing 
events occurring between stages 10 and 14-15 were shared between X.laevis and 
X.tropicalis as reported by vast-tools and SUPPA. This might be due to variability in splicing 
event detection numbers between different splicing tools, but also due to whole embryo bulk 




As outlined in section 1.1, intron retention is an important contributor to post-transcriptional 
regulation of gene expression and transcript diversity during normal differentiation and 
development (Pimentel et al., 2016b; Middleton et al., 2017). Splicing isoform diversity is 
highest in undifferentiated stem cells and decreases upon neural commitment and 
differentiation (Wu et al. 2010), and IR has been suggested to promote the elimination of 
non-functional or physiologically irrelevant transcripts and isoforms (Braunschweig et al., 
2014). One consistent pattern that has emerged across many biological contexts is that 
regulatory IR particularly affects spliceosome components and splicing factors (Pimentel et 
al., 2016b; Jacob and Smith, 2017); Boutz et al. 2015). In most cases IR events in splicing 
factor pre-mRNAs act to down-regulate expression of those SFs. Splicing analysis of RNA-
Seq data from whole X.tropicalis embryos suggests an increase in intron retention levels as 
X.tropicalis neurogenesis progresses, including in transcripts of splicing regulators like 
Hnrnpd and Rbfox2 (Figure 8A).  
SUPPA was used to see whether IR events would cluster across X.laevis developmental 
stages 10,15,25 and whether the genes within those clusters would have roles in similar 
biological processes and pathways. For a maximum reachability distance of 0.15, I obtained 
three well-differentiated clusters (silhouette score = 0.387; Figure 8B; Supplementary table 
2). Given the variability of events across stages, it is hard to find compact core clusters, 
therefore the minimum number of events per cluster was set to 5. Once the first cluster 
definition is overcome, it is easier to identify events in the neighbourhood. Functional 
enrichment analysis of the largest cluster (Cluster 1, 361 genes) revealed it to be enriched for 
GO terms relating to RNA splicing(GO:0008380), localization (GO:0006403) and 
transport(GO:0050658). Levels of intron retention in that cluster rose between stages 10 and 
15 and fell again at stage 25. The other two clusters showed an opposite pattern wherein the 
levels of intron retention were lowest at stage 15, the bigger of the two clusters showed 
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enrichment for genes involved in stem cell differentiation (GO:0048863) and the PI3K/AKT 






Figure 8. Intron retention levels in differentially spliced transcripts increase during 
X.tropicalis developmental stages relevant to neurogenesis.  
(A) Heatmap of intron retention events represented as Z-scores of percent-spliced in (PSI) 
values, reported by VAST-TOOLS (p < 0.1, |dPSI| > 10), across X. tropicalis developmental 
stages 10,14 and 15 (GSE37452), with the corresponding hierarchical clustering. (B) The 
average PSI (y-axis, where 1 indicates 100%) per stage (x-axis) of the intron retention events 
in the three clusters obtained. Density-based clustering performed on the 510 regulated 
intron retention events that change splicing significantly in at least one comparison between 
adjacent steps across three differentiation stages (10,15,25).  
 
3.3: Xenopus neural plate and crest development are regulated by alternative splicing 
 
As mentioned previously, low read depth and heterogeneity of whole organism cell 
populations lead to variations in transcript expression between samples and conditions to be 
dominated by technical or biological noise. To minimise the effects of expression noise, as 
that observed in aforementioned whole embryo datasets, and focus on regions relevant to 
neurogenesis, transcriptomic data from defined cell populations of developing X.laevis 
ectoderm was selected for analysis (GSE103240; (Plouhinec et al., 2017). X.laevis embryos 
were dissected at Nieuwkoop and Faber stages 12.5, 14 and 17 which correspond 
respectively with the transition from gastrulation to neurulation, mid- and late neurula. 3 
biological replicates were collected per dissected region for all three stages. RNA-Seq data 
from regions of lineage progenitors for neural plate (NP), neural crest (NC), which emerges 
from neural plate border (NB) cells, and non-neural ectoderm (NNE) was selected for this 
project. The structures were subdivided into anterior and posterior regions. The anterior NP 
forms the forebrain and the midbrain, whilst the posterior NP forms the hindbrain and the 





























at that stage. RNA-Seq libraries were sequenced on an Illumina HiSeq 2000 machine with a 
target of 15–20 million 100 bp paired reads per sample.  
As discussed previously, precise spatio-temporal regulation of spliceosome machinery and 
SF expression is essential during neural development. The authors reported that the “mRNA 
splicing” GO term was enriched in 6 of the weighted gene co-expression network analysis 
groups. These are groups of genes that share similar temporal and spatial expression 
profiles.  
Despite N1-Src knockdown causing failure of all neuronal types in the Xenopus primary 
nervous system to differentiate, NB and NC were regions of particular interest due to them 
being the supposed origin of neuroblastoma. As mentioned in section 1.7, overexpression of 
N-Srcs has been shown to differentiate neuroblastoma cell lines derived from metastatic high 
risk tumours and therefore our hypothesis is that N-Src regulated splicing might be a good 
target for neuroblastoma therapy.  
Motif enrichment analysis of the 56 DS junction sequences suggests that putative Src-
substrates SRSF1 and RBM47 are amongst regulators of IR during the development of 
neural crest in Xenopus between stages 14 and 17 (Table 3). 7 out of the 34 annotated 
genes that underwent IR are RNA-binding proteins and regulators of translation.  
 
Table 3. Consensus motifs of putative Src substrates SRSF1 and RBM47 are enriched 
at intron retention splice junctions in developing X.laevis neural crest. RNA binding 
protein motif enrichment within a 135bp window around the splice sites of differential splicing 
events occurring during the transition of neural border at st.14 to neural crest at st17 was 
calculated using AME one-tailed Fisher’s exact test (E-value < 10, p <= 0.05). Putative Src 
substrates are indicated in bold. The adj-p-value represents the optimal enrichment p-value 
of the motif, adjusted for multiple tests using a Bonferroni correction. The E-value is the adj-
p-value multiplied by the number of motifs in the motif file and represents the expected 
number of motifs that would be as enriched in the submitted sequences as this one.  
Event Motif RBP consensus adj_p-value E-value 
IR CNOT4_00156 GACAGAN 9.20E-04 9.85E-02 
IR ENOX1_00149 MAGACAG 4.33E-03 4.63E-01 
IR SRSF1_00163 GGAGGAG 1.30E-02 1.39E+00 
IR PCBP3_00215 HTTTCCCT 2.09E-02 2.23E+00 
IR TRA2_00078 GAAGAAG 2.66E-02 2.85E+00 
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IR RBM47_00279 GATGAWN 3.05E-02 3.26E+00 
IR RBM45_00241 GACGACM 3.81E-02 4.07E+00 
 
Next transcriptomes and splicing profiles of anterior neural plate sections were analysed. 
Differential gene expression analysis with Sleuth was performed to confirm mRNA splicing as 
an important mechanism regulating central nervous system development. GO term 
enrichment analysis showed that genes that are differentially expressed in Xenopus neural 
plate development are linked to neuron differentiation, regulation of phosphorylation, 
transcription and RNA processing. Most of the differentially expressed genes involved in 
splicing were downregulated (Figure 9). Interestingly, 31 of the 153 downregulated SF genes 
are putative Src substrates, including SRSF1, SRSF9 and NONO. The downregulation of SF 
expression supports the observation that transcript diversity declines during differentiation 
and therefore splicing regulator expression falls allowing only the physiologically relevant 
transcripts to be successfully spliced.  
SUPPA reported various differential splicing events occurring during X.laevis NP 
development, however many of them occurred in unannotated transcripts and genes of 
unknown function. Out of the 201 annotated transcripts, only 76 belonged to a gene with a 
described function. Two of these genes are RNA processing regulators Ptbp1 and Igf2bp3 
























Figure 9: Xenopus neural plate development involves differential expression and 
splicing of genes coding for regulators of RNA processing.   
(A) Analysis of Gene Ontology term enrichment among genes whose expression changes 
between stages 12.5 and 14-15 of X.laevis neural plate development. GO clusters enriched 
for downregulated genes are indicated in red, for upregulated genes in green. (B) Volcano 
plot highlighting differential exon skipping events occurring in X.laevis neural plate between 
stages 12.5 and 14-15, with events considered significant  at  p<0.1, |dPSI| > 0.1. (C) 
Heatmap of exon skipping events represented as Z-scores percent-spliced in (PSI) values, 
reported by VAST-TOOLS (p < 0.1, |dPSI| > 10), across X. tropicalis ectodermal tissues: 
anterior neural plate (NPa) and nonneural ectoderm (NNE) at stages 12.5 and 14 
(GSE37452), with the corresponding hierarchical clustering. 
 
3.4: N1-Src knockdown and v-Src expression cause changes in splicing of splicing 
factors TRA2A and HNRNPA1 
 
Insights gained from the unpublished N1-Src knockdown data produced in the Evans lab have 
been the foundation of the current project. The knockdown in Xenopus embryos was achieved 
through the use of antisense morpholino oligos (MOs)  that specifically bind to their selected 
target site to block access of cell components to that site. X.tropicalis embryos at the 1-2-cell 
stage were injected bilaterally with 20ng non-overlapping antisense MOs targeted to the splice 
acceptor and donor sites of the n1-src microexon or  20ng standard control MOs. This way c-
Src expression was unaffected by the antisense MO injection. Four biological repeats were 
carried out and mRNA for short-read sequencing was harvested at stage 16. Bioinformatic 
analysis and experimental validation with PCR previously done by the Isaacs and Evans labs 
revealed that N1-Src knockdown causes intron retention in transcripts of key splicing factors 
TRA2A and HNRNPA1 (Fig 10). It provided more evidence for the hypothesis that N1-Src 
regulates the splicing of splicing factors during primary neurogenesis. These two PCR-
validated splicing events have been used in the current project as guidance during choice of 
differential splicing analysis tools. According to analysis with VAST-TOOLS, v-Src expression 
in MCF10-ER-Src human cell line promotes alternative splicing in transcripts of TRA2A and 
HNRNPA1, further validating Src’s role in their regulation. However, instead of having an 
opposite effect on intron retention, v-Src activation caused the same intron retention in TRA2A 
but an alternative 3’ acceptor site in HNRNPA1 transcript. The exon junctions at either side of 
the intron retention event in TRA2A contain SRSF1 and SRSF9 binding sites, along with a 
TRA2A binding site in the downstream exon (Figure 10C). This only implied that all of these 
putative Src substrates are key regulators and so most transcripts contain many of their 
binding consensus motifs at the exon junctions. A binding motif of tra2, a TRA2A orthologue in 
Drosophila, was enriched at exon junctions involved in intron retention events regulated during 
specification of neural crest in X.laevis embryos. This suggests an extra level to N1-Src 
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regulation of alternative splicing, whereby phosphorylation of one set of splicing factors 
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Figure 10. N1-Src knockdown in frog embryos and v-Src expression in a human 
MCF10-ER-Src cell line cause alternative splicing in transcripts of splicing factors 
HNRNPA1 and TRA2A.   
(A) Volcano plot highlighting significant differential exon skipping events (p<0.1, |dPSI| > 0.1) 
that occur upon N1-Src knockdown. (B) Venn diagram showing the overlap among the 
differentially spliced genes following N1-Src knockdown in X.tropicalis embryos, v-Src 
activation in human cell line and normal development of X.tropicalis embryo. Splicing factors 
are indicated in bold. (C) Instances of SRSF1, SRSF9 and TRA2A binding motifs within the 
chromosome sequence (chr7:23521841-23531788) surrounding the TRA2A intron that is 
retained after v-Src expression is activated in MCF10-ER-Src cells. The dotted line down the 
middle acts as a 'broken axis' for the intron.  
 
Chapter 4: Discussion 
 
N1-Src is a tyrosine kinase known to be essential in the normal development of the 
nervous system both during early neurogenesis and later stages of neuron morphogenesis 
(Keenan et al., 2017; Lewis et al., 2017). Its high expression has also been shown to 
correlate with the differentiation of neuroblastoma cells (Matsunaga et al.,1993). However, its 
mechanism of action remains less understood. Preliminary transcriptomic and 
phosphoproteomic data suggest N1-Src to be a regulator of splicing. In this study, we have 
further investigated the implication of specific alternative splicing events and factors in N1-
Src induced neurogenesis. 
 4.1: Src regulates the splicing of splicing factors  
 
By analysing data from human and Xenopus models, we show that Src is a conserved 
regulator of the splicing of splicing factors. Evolutionary conservation provides evidence for 
functional significance of Src’s role in modulation AS patterns. Similarly to N1-Src in 
X.tropicalis embryos, v-Src expression in human MCF10-ER-Src cells regulates alternative 
splicing of SFs hnRNPA1 and TRA2A. Interestingly, instead of having opposite effects, both 
the N1-Src knockdown and induction of v-Src expression cause an intron retention event in 
the TRA2A transcripts to occur. We also confirm that splicing of splicing factors occurs during 
normal Xenopus neurula. As mentioned in section 1.6, hnRNPA1 represses N1-Src splicing 
in vitro (Rooke et al., 2003), therefore N1-Src regulation of HNRNPA1 splicing might be part 
of a feedback loop.  
Signalling-activated kinases have previously been shown to mediate SF localization and 
activity through phosphorylation (Naro and Sette 2013). For example, SR protein kinase 
(SRPK)-mediated phosphorylation of SRSF1 RS domain is required for its nuclear import and 
for its interaction with U1snRNP, thus promoting spliceosome assembly (Long et al. 2019; 
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Gonçalves et al. 2014). This suggests a mechanism to N1-Src regulation of neurogenesis, 
whereby phosphorylation of one set of splicing factors promotes changes in splicing of a new 
set of SFs which then leads to global changes in alternative splicing patterns.  
 
The primary aim of this work has been to look for correlations between DS events, splicing 
regulator expression and motif enrichment across different biological settings. This would 
help us identify potential splicing factor targets of Src regulation that play roles in vertebrate 
nervous system development. Unfortunately, little overlap was not only seen between results 
of analysis of different datasets but also analysis of the same datasets with different 
bioinformatics tools. This issue can be explained by the differences in algorithms and 
approaches used by these tools but also by features of the datasets themselves. 
  
As mentioned in section 1.2, most RBP binding motif sequences are short and occur 
frequently in differentially spliced transcripts. This limited the ability of AME to achieve both 
high specificity and sensitivity in reporting the enriched motifs from the CISBP-RNA database 
as these motifs tend to appear frequently in the genome. As with the case of SRSF1, the 
effect of many splicing regulators’ binding depends on its location in regard to the exon 
junction. Therefore, the Matt RNA map function was a much more useful tool as it provided 
information on spatial distribution of the enriched motifs. Unfortunately, this option was only 
available for the human dataset as it did not cover Xenopus RBPs and therefore could not 
determine the motif distribution for the developmental series datasets. 
  
Additionally, the current advice for experiments looking for information on alternative splicing 
is that they require a sequencing depth of 20–60 million reads per sample. The read 
coverage for the X.tropicalis and MCF10A-vSrc datasets was under 10 million reads, which is 
only really enough for differential gene expression analysis. As justified previously, the use of 
the vast-tools diff module enabled the correction for biases caused by low numbers of reads 
for these datasets, however combining files and reducing the number of replicates has an 
inevitable impact on statistical analysis. Therefore, future DS analysis should only be 
undertaken in cases where relevant deep sequencing datasets are available. 
 
One putative Src substrate that consistently appeared as a regulator of DS events across 
different datasets was the essential splicing regulator SRSF1. It was identified as a regulator 
of Alt3’ splice site events in the human cell line and as a regulator of intron retention during 
normal X.laevis neural crest development. Additionally, the preliminary motif enrichment 
analysis done by the York Genomics and Bioinformatics facility upon the N1-Src knockdown 
X.tropicalis embryo RNA-Seq data indicated SRSF9 to be a regulator of splice site selection 
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(Katherine Newling). Its binding motifs are enriched at the DS junctions of both IR and exon 
skipping events. RBP maps produced by Matt suggested that in cells where v-Src is 
expressed SRSF1 and SRSF9 binding to regions in the regulated exons leads to exon 
skipping. According to James Ormond’s data analysis (unpublished MSc dissertation), the 
phosphorylation motifs recognised by Src in the RRM1 domains of SRSF1 and SRSF9 are 
very similar and therefore potentially closely related. 
4.2 : Regulation of splicing as a therapeutic strategy 
  
Disruptions in alternative splicing patterns have been associated with a range of 
neurodevelopmental and neurodegenerative disorders and cancer (Sanders et al. 2020; 
Porter et al. 2018). High-risk neuroblastoma has been associated with high expression levels 
of spliceosomal components and regulatory splicing factors, including HNRNPA1. 
Additionally, recent experiments showed that selective spliceosome inhibition with 
pladienolide B reduces tumour growth in vivo (Shi et al., 2020) In the study presented here 
more evidence to support the previous observations that some splicing factors are 
downregulated during normal neuronal differentiation and that one of the proposed 
mechanisms that regulate this process is IR, which is increased during neurogenesis.  
High levels of N1-Src are a positive prognostic predictor in neuroblastoma. In section 3.3, it 
was shown that consensus RNA binding motifs of the putative Src-substrates SRSF1 and 
RBM47 are enriched at junctions of IR events regulated during normal neural crest 
development in X.laevis. This presented an idea for a mechanism in which the disruption of 
normal Src-mediated intron retention events would lead to over- or aberrant expression of 
splicing factors in the developing neural crest. Potentially, due to the SUPPA algorithm being 
less sensitive to IR events, the few genes identified were enriched for RNA binding but not 
splicing. Therefore, more transcriptomic data would be needed to confirm this hypothesis.  
Interestingly, N1-Src knockdown and overexpression seem to have similar, instead of 
opposite, effects on the processes it regulates  (Kotani et al. 2007; Keenan et al. 
2017).  Therefore, simply increasing the levels of N1-Src would not be a suitable therapeutic 
strategy for neuroblastoma as its expression has a global effect on a complex splicing 
programme. However, antisense oligonucleotide (ASO) drugs that module the AS of specific 
genes are being developed to treat nervous system disorders. Nusinersen is a clinically 
approved ASO medication used in treating spinal muscular atrophy via altering exon 
inclusion in the SMN1 transcript and promoting the production of the full-length SMN protein 
(Chiriboga 2017). Similar therapies could be explored and developed specifically for each 




The results of this project so far provide a starting point for further laboratory research. They 
further describe the key players in the splicing cascade regulated by Src phosphorylation 
during neuronal development. In the future, protein-centric methods of studying RNA-protein 
interaction, such as HITS-CLIP can be used to investigate which splicing events and isoform 
switches are regulated by the splicing factors phosphorylated by Src (Licatalosi et al., 2008; 




Definitions and abbreviations 
 
Alt3 Alternative 3’ site 
Alt5 Alternative 5’ site  
AS Alternative splicing  
DNA Deoxyribonucleic acid 
ESE Exonic splicing enhancer 
ESS Exonic splicing silencer 
hnRNP heterogeneous nuclear ribonucleoprotein 
IR intron retention 
ISE Intronic splicing enhancer  
ISS Intronic splicing silencer  
MO Morpholino oligo 
mRNA Messenger ribonucleic acid  
NB Neural plate border  
NC Neural crest 
NMD Nonsense mediated decay  
NNE Non-neural ectoderm  
NP Neural plate  
NPC Neural progenitor cell  
nt Nucleotide  
PTB Polypyrimidine-tract-binding protein 
PTC Premature termination codon 
P-value Probability value 
RA Retinoic acid  
RBP RNA binding protein  
RNA Ribonucleic acid  
SE Exon skipping  
SF Splicing factor 
SFK Src family kinase 
snRNP small nuclear ribonucleoprotein particle 
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